PEGASYS Safety Questions, PEGASYS Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about PEGASYS. Our extensive database of PEGASYS adverse events and PEGASYS warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about PEGASYS

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




PEGASYS Safety Reports

Total PEGASYS reports: 1211.
PEGASYS FDA safety alerts: No.
Reported deaths: 66    Reported hospitalizations: 499.
Take PEGASYS Side Effects Survey or Share Your PEGASYS Story. PEGASYS Usage.

Showing 1-75 of 1211 Next >

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Jan 23, 2007. Female patient, 48 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: anaemia, anxiety, asthenia, chills, delirium, depressive symptom, dry mouth, fatigue, haemoglobin decreased. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, CYMBALTA, VICODIN, FOLIC ACID, BOTOX. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 22, 2007. Male patient, 51 years of age, was diagnosed with somnolence, back pain, depression and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: arthralgia, bipolar i disorder, headache, musculoskeletal pain, weight decreased. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, SKELAXIN, AMBIEN, FLEXERIL, BENADRYL, WELLBUTRIN. Patient recovered.

Physician from SWEDEN reported PEGASYS problem on Jan 25, 2007. Female patient, 38 years of age, was diagnosed with hepatitis and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, ASACOL, TENORMIN. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Jan 23, 2007. Female patient, 62 years of age, weighting 127.9 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: anaemia, chills, haematuria, rash. PEGASYS dosage: unknown. During the same period patient was treated with ROBATROL. Patient recovered.

Physician from JAPAN reported PEGASYS problem on Jan 24, 2007. Male patient, 58 years of age, weighting 70.55 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: aspergillosis, interstitial lung disease, malaise. PEGASYS dosage: unknown. During the same period patient was treated with GLYCYRON, PROHEPARUM, LOPEMIN. Patient was hospitalized. Patient died on 12/21/2006.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2007. Female patient, 57 years of age, weighting 119.9 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: asthenia, ophthalmological examination abnormal, rash, visual acuity reduced, white blood cell count decreased. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, NEUPOGEN. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported PEGASYS problem on Jan 26, 2007. Female patient, 57 years of age, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: dental caries, dry mouth. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2007. Female patient, 57 years of age, weighting 119.9 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: asthenia, ophthalmological examination abnormal, rash, visual acuity reduced, white blood cell count decreased. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, NEUPOGEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Jan 25, 2007. Male patient, 59 years of age, weighting 179.9 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: depressed mood, dyspnoea, insomnia, nephrolithiasis. PEGASYS dosage: unknown. During the same period patient was treated with RIBAPAK. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from SWITZERLAND on Jan 26, 2007. Female patient, 57 years of age, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: dental caries, dry mouth. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Jan 19, 2007. Male patient, 47 years of age, weighting 199.0 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaemia, asthenia, back pain, bone pain, cold sweat, confusional state, cough, dehydration. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2007. Female patient, 69 years of age, weighting 149.9 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: alopecia, fatigue, haemoglobin decreased, pulmonary hypertension, red blood cell count decreased, weight decreased, white blood cell count decreased. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, COUMADIN, SYNTHROID. Patient recovered.

Health Professional from UNITED STATES reported PEGASYS problem on Jan 26, 2007. Female patient, 62 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: balance disorder, metal poisoning, muscular weakness, no therapeutic response. PEGASYS dosage: unknown. Patient recovered.

PEGASYS problem was reported by a Physician from NETHERLANDS on Jan 26, 2007. Male patient, 59 years of age, was diagnosed with polycythaemia vera, hypertension and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: hypertension, malaise, nephropathy toxic. PEGASYS dosage: unknown. During the same period patient was treated with ROFERON, HYDREA, SELOKEEN. Patient recovered.

Physician from JAPAN reported PEGASYS problem on Jan 26, 2007. Female patient, 66 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, platelet count decreased, pneumonia, systemic lupus erythematosus. PEGASYS dosage: unknown. Patient was hospitalized. Patient recovered.

PEGASYS problem was reported by a Physician from ITALY on Jan 27, 2007. Female patient, 66 years of age, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: aneurysm ruptured, angina pectoris. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, EPREX. Patient died on 05/11/2006.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Jan 23, 2007. Female patient was diagnosed with hepatitis c, tonsillitis and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: allergy to chemicals, blood glucose decreased, diarrhoea, extrasystoles, food allergy, house dust allergy, influenza like illness, intervertebral disc protrusion. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, OMNICEF, VITAMINS NOS. Patient was hospitalized. Patient recovered.

PEGASYS problem was reported by a Physician from JAPAN on Jan 29, 2007. Female patient, 62 years of age, weighting 110.2 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: retinal detachment. PEGASYS dosage: unknown. Patient recovered.

Physician from JAPAN reported PEGASYS problem on Jan 30, 2007. Female patient, 44 years of age, weighting 99.21 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: menstrual disorder, urticaria, vaginal erosion. PEGASYS dosage: unknown. During the same period patient was treated with LOXONIN, LENDORMIN. Patient recovered.

PEGASYS problem was reported by a Physician from GERMANY on Jan 30, 2007. Female patient, 33 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported PEGASYS problem on Jan 30, 2007. Male patient, 43 years of age, weighting 127.9 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: nephrotic syndrome. PEGASYS dosage: unknown. During the same period patient was treated with OLMETEC. Patient was hospitalized. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2007. Female patient, 54 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: fatigue, hypothyroidism, nephrolithiasis, no therapeutic response, viral load increased, white blood cell count decreased. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported PEGASYS problem on Jan 29, 2007. Female patient, 53 years of age, weighting 140.0 lb, was diagnosed with hepatitis c, depression and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, blood glucose increased, constipation, cough, dry mouth, dry skin, fatigue, haemolytic anaemia. PEGASYS dosage: unknown. During the same period patient was treated with RIBASPHERE, PROZAC, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from FRANCE on Feb 01, 2007. Female patient, 46 years of age, weighting 110.2 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: delusion, depression, hypercalcaemia, irritability, major depression. PEGASYS dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported PEGASYS problem on Jan 29, 2007. Male patient, 47 years of age, weighting 199.1 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaemia, asthenia, back pain, bone pain, cold sweat, confusional state, cough, decreased appetite. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

PEGASYS problem was reported by a Physician from UNITED STATES on Feb 02, 2007. Male patient, 67 years of age, weighting 123.7 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: anaemia, hypotension. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported PEGASYS problem on Jan 31, 2007. Male patient, 44 years of age, weighting 154.3 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: vogt-koyanagi-harada syndrome. PEGASYS dosage: unknown. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Female patient, 56 years of age, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Jan 29, 2007. Male patient, 48 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: haemoptysis, injection site reaction, oedema peripheral. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from FRANCE on Jan 29, 2007. Female patient, 56 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: agranulocytosis. PEGASYS dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Jan 29, 2007. Male patient, 45 years of age, weighting 287.0 lb, was diagnosed with arthritis and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: arthritis, diabetes mellitus, loss of consciousness. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, CELEBREX, NEXIUM, REQUIP. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2007. Male patient, 50 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, bone pain, dehydration, hepatitis c, thrombocytopenia. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, TRUVADA, SUSTIVA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Jan 31, 2007. Female patient, 24 years of age, was diagnosed with anxiety, depression, back pain, constipation and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: dehydration, injection site extravasation, malaise, procedural complication, pyrexia, suicidal ideation, vomiting, white blood cell count decreased. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, KLONOPIN, XANAX, PEXEVA, DILAUDID, LACTULOSE. Patient recovered.

PEGASYS problem was reported by a Physician from UNITED STATES on Jan 29, 2007. Female patient, 51 years of age, weighting 185.0 lb, was diagnosed with hepatitis c, pain and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: cholecystitis, cholelithiasis, nausea. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, METHADONE. Patient recovered.

Consumer or non-health professional from CHINA reported PEGASYS problem on Jan 15, 2007. Male patient, 31 years of age, was diagnosed with hepatitis b and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. PEGASYS dosage: unknown. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from SWEDEN on Feb 01, 2007. Female patient, 39 years of age, was diagnosed with hepatitis and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, ASACOL, TENORMIN. Patient recovered.

Physician from GERMANY reported PEGASYS problem on Feb 01, 2007. Female patient was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Male patient, 50 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: blood magnesium decreased, blood potassium decreased, dysphonia, epistaxis, fatigue, haemoptysis, muscle spasms, pharyngeal mass, thyroid disorder. PEGASYS dosage: STRENGTH REPORTED AS 180UG/0.5ML. During the same period patient was treated with RIBAVIRIN, ANTIDEPRESSANT NOS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Feb 01, 2007. Female patient, 44 years of age, was diagnosed with hepatitis c, depression, insomnia and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: no therapeutic response, thrombosis. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, EFFEXOR, TRAZODONE, ADVAIR DISKUS, ALBUTEROL. Patient recovered.

PEGASYS problem was reported by a Physician from GERMANY on Feb 05, 2007. Female patient, 59 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: headache, optic atrophy. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported PEGASYS problem on Feb 02, 2007. Male patient, 54 years of age, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: retinal detachment. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2007. Female patient, 55 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: breast mass, cough, dry skin, dyspepsia, dyspnoea, eczema, fatigue, memory impairment, vision blurred. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Jan 31, 2007. Male patient, 59 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, depression, dizziness, dyspnoea exertional, ear pain, fatigue, headache, hypoaesthesia. PEGASYS dosage: STRENGTH REPORTED AS: 180 MCG/0.5 ML.. During the same period patient was treated with RIBAVIRIN. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 02, 2007. Female patient, 45 years of age, weighting 106.9 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: alopecia, ankylosing spondylitis, chest pain, dehydration, diarrhoea, dry mouth, dyspnoea, fatigue, hallucination. PEGASYS dosage: THE PATIENT INJECTED SUBCUTANEOUS PEGASYS 180 MCG/0.5 ML WEEKLY.. During the same period patient was treated with RIBAVIRIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Feb 02, 2007. Male patient, 24 years of age, weighting 205.0 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: dehydration, pleurisy. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

PEGASYS problem was reported by a Physician from UNITED STATES on Feb 02, 2007. Male patient, 52 years of age, weighting 225.1 lb, was diagnosed with hepatitis c, renal hypertension and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, haemoglobin decreased, pulmonary embolism. PEGASYS dosage: STRENGTH REPORTED AS 180 MCG/0.5 ML.. During the same period patient was treated with COPEGUS, LISINOPRIL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PEGASYS problem on Dec 01, 2006. Male patient, 55 years of age, weighting 200.0 lb, was diagnosed with hepatitis c virus, anaemia, anxiety, sleep disorder and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: anaemia, deep vein thrombosis, insomnia. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, PROCRIT, ZOLOFT, LUNESTA. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 02, 2007. Female patient, 45 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: cardiomegaly, fatigue. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Feb 06, 2007. Female patient, 46 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: ageusia, anaemia, anorexia, anxiety, asthenia, blood potassium decreased, bone pain, burning sensation, crying. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient was hospitalized. Patient recovered.

PEGASYS problem was reported by a Physician from GERMANY on Feb 06, 2007. Male patient, 65 years of age, weighting 158.7 lb, was diagnosed with gastrectomy and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: metastases to bone, prostate cancer, prostatic specific antigen increased. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, VITAMIN B. Patient recovered.

Physician from FRANCE reported PEGASYS problem on Feb 05, 2007. Male patient, 46 years of age, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: tendonitis. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN. Patient recovered.

PEGASYS problem was reported by a Physician from UNITED STATES on Feb 07, 2007. Female patient, 60 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: precancerous cells present. PEGASYS dosage: unknown. Patient recovered.

Physician from NETHERLANDS reported PEGASYS problem on Feb 08, 2007. Male patient, 58 years of age, was diagnosed with polycythaemia vera, hypertension and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: hypertension, malaise, nephropathy toxic, proteinuria, renal failure. PEGASYS dosage: unknown. During the same period patient was treated with ROFERON, HYDREA, SELOKEEN, ENALAPRIL MALEATE. Patient recovered.

PEGASYS problem was reported by a Physician from UNITED STATES on Feb 08, 2007. Female patient, 45 years of age, weighting 106.9 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: alopecia, ankylosing spondylitis, chest pain, dehydration, diarrhoea, dry mouth, dyspnoea, fatigue, hallucination. PEGASYS dosage: THE PATIENT INJECTED SUBCUTANEOUS PEGASYS 180 MCG/0.5 ML WEEKLY.. During the same period patient was treated with RIBAVIRIN. Patient was hospitalized. Patient recovered.

Pharmacist from JAPAN reported PEGASYS problem on Feb 07, 2007. Female patient, 59 years of age, weighting 110.2 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, pleural effusion, pleurisy. PEGASYS dosage: unknown. During the same period patient was treated with GLYCYRON, AMOBAN. Patient was hospitalized. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2007. Female patient, 49 years of age, weighting 183.0 lb, was diagnosed with depression and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: dyspnoea, heart rate increased, pericardial effusion, pneumonia bacterial, rash pruritic. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, ADVAIR DISKUS, SPIRIVA, ALBUTEROL, THEOPHYLLINE, SINGULAIR, RITALIN, DOXEPINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PEGASYS problem on Feb 05, 2007. Female patient, 53 years of age, weighting 240.1 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, breast mass, cough, dizziness, fatigue, hepatic cirrhosis, hepatic pain, hypotrichosis. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, PROTONIX, BENADRYL. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2007. Male patient, 60 years of age, weighting 175.0 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: myoclonus. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN. Patient recovered.

Physician from JAPAN reported PEGASYS problem on Feb 09, 2007. Male patient, 58 years of age, weighting 70.55 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: aspergillosis, interstitial lung disease, malaise. PEGASYS dosage: unknown. During the same period patient was treated with GLYCYRON, PROHEPARUM, LOPEMIN. Patient was hospitalized. Patient died on 12/21/2006.

PEGASYS problem was reported by a Physician from JAPAN on Feb 08, 2007. Male patient, 43 years of age, weighting 127.9 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: nephrotic syndrome. PEGASYS dosage: unknown. During the same period patient was treated with OLMETEC. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Feb 06, 2007. Male patient, 48 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: dyspnoea, fistula, hepatic cirrhosis, open wound, platelet count abnormal, red blood cell count decreased, sinus disorder, white blood cell count decreased. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2007. Female patient, 45 years of age, was diagnosed with hepatitis c virus, prophylaxis and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, arthralgia, back pain, dehydration, diarrhoea, dizziness, dyspnoea, dyspnoea exertional. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, TRANQUILIZERS, CYMBALTA, XANAX, SLEEPING NOS, HEPATITIS A VACCINE. Patient recovered.

Physician from GERMANY reported PEGASYS problem on Feb 12, 2007. Female patient, 33 years of age, weighting 145.5 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient was hospitalized. Patient recovered.

PEGASYS problem was reported by a Health Professional from AUSTRALIA on Feb 07, 2007. Female patient, 42 years of age, weighting 188.7 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: agitation, anxiety, arthralgia, depression, fatigue, hallucination, auditory, headache, insomnia, myalgia. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, THIAMINE, NALTREXONE, PAROXETINE, QUETIAPINE FUMARATE, VALPROATE, VOLTAREN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PEGASYS problem on Feb 12, 2007. Female patient, 46 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: anaemia, disturbance in attention, dizziness, fatigue, vision blurred, visual disturbance. PEGASYS dosage: unknown. During the same period patient was treated with RIBASPHERE. Patient recovered.

PEGASYS problem was reported by a Health Professional from UNITED STATES on Feb 15, 2007. Male patient was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: depression, sleep apnoea syndrome. PEGASYS dosage: unknown. Patient died on 12/01/2006.

Physician from UNITED STATES reported PEGASYS problem on Feb 12, 2007. Female patient, 51 years of age, weighting 185.0 lb, was diagnosed with hepatitis c, pain and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: bronchitis, cholecystitis, cholelithiasis, malaise, nausea, productive cough, white blood cell count decreased. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, METHADONE. Patient recovered.

PEGASYS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2007. Male patient, 68 years of age, was diagnosed with respiratory tract congestion and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: anaemia, constipation, cough, dry skin, haematocrit decreased, haemoglobin decreased, influenza like illness, insomnia, prostate examination abnormal. PEGASYS dosage: STRENGTH REPORTED AS 180MCG/0.5ML.. During the same period patient was treated with RIBAVIRIN, DIPHENHYDRAMINE. Patient recovered.

Health Professional from CANADA reported PEGASYS problem on Feb 15, 2007. Male patient, 46 years of age, was diagnosed with hepatitis c, anaemia and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, haemoglobin decreased. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS, EPREX. Patient was hospitalized. Patient recovered.

PEGASYS problem was reported by a Health Professional from UNITED KINGDOM on Feb 12, 2007. Male patient, 43 years of age, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

Physician from GERMANY reported PEGASYS problem on Feb 15, 2007. Female patient was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

PEGASYS problem was reported by a Health Professional from UNITED STATES on Feb 12, 2007. Female patient, 53 years of age, weighting 149.9 lb, was diagnosed with hepatitis c, rash, back pain, hypertension, depression and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: alopecia, burning sensation, chills, clubbing, confusional state, dehydration, dermatitis infected, diarrhoea, disturbance in attention. PEGASYS dosage: STRENGTH: 180 MCG/0.5 ML.. During the same period patient was treated with RIBAVIRIN, BENADRYL, ULTRAM, HYZAAR, CELEXA. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PEGASYS problem on Feb 12, 2007. Female patient, 53 years of age, weighting 149.9 lb, was diagnosed with hepatitis c, rash, back pain, hypertension, depression and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: alopecia, burning sensation, chills, clubbing, confusional state, dehydration, dermatitis infected, diarrhoea, disturbance in attention. PEGASYS dosage: STRENGTH: 180 MCG/0.5 ML.. During the same period patient was treated with RIBAVIRIN, BENADRYL, ULTRAM, HYZAAR, CELEXA. Patient was hospitalized. Patient recovered.

PEGASYS problem was reported by a Pharmacist from UNITED STATES on Feb 16, 2007. Male patient, 49 years of age, weighting 173.9 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, polymyositis. PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, LISINOPRIL, NIFEDIPINE, ATENOLOL. Patient recovered.

Physician from FRANCE reported PEGASYS problem on Feb 19, 2007. Female patient, 60 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome. PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

Showing 1-75 of 1211 Next >

Ask Our Patient Community about PEGASYS

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
Pa